Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity

NCT05492318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-Drug Interaction
Heathy Volunteer

Interventions

DRUG: Givinostat 10 mg/mL
DRUG: Midazolam 1mg/ml IV
DRUG: Midazolam 2.5 mg oromucosal solution
DRUG: Dabigatran etexilate 75 mg oral hard capsules

Sponsor

Italfarmaco